Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Perrigo Company    PRGO

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 5 672 M
EBIT 2016 1 577 M
Net income 2016 663 M
Debt 2016 4 606 M
Yield 2016 0,51%
Sales 2017 5 958 M
EBIT 2017 1 698 M
Net income 2017 838 M
Debt 2017 3 834 M
Yield 2017 0,75%
P/E ratio 2016 31,37
P/E ratio 2017 17,88
EV / Sales2016 3,10x
EV / Sales2017 2,83x
Capitalization 13 002 M
More Financials
Company
Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products.It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences.The CHC segment includes... 
Sector
Pharmaceuticals
Calendar
10/20Earnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
07/27 Teva, Allergan win U.S. antitrust approval for generics deal
07/18 PERRIGO : Facebook trade offers a 30% return in 32 days, or find similar option ..
07/16 PERRIGO SHAREHOLDER JULY 18 DEADLINE : Shareholder Rights Law Firm Johnson & Wea..
07/16 JULY 18 DEADLINE ALERT : Law Offices of Howard G. Smith Reminds Investors of the..
07/15 PERRIGO : Glancy Prongay & Murray Announces the Filing of a Securities Class Act..
07/14 Goldberg Law PC Announces Securities Class Action Lawsuit against Perrigo Com..
07/14DJValeant's Ex-CEO Michael Pearson Sells Nearly $100 Million in Company Stock -..
07/14DJPearson Sells Large Valeant Stake -- WSJ
07/13DJValeant's Ex-CEO Michael Pearson Sells Nearly $100 Million in Company Stock
07/13 PERRIGO : The Law Offices of Howard G. Smith Announces the Filing of a Securitie..
More news
Sector news : Pharmaceuticals - NEC
07/27 Teva, Allergan win U.S. antitrust approval for generics deal
07/27DJTEVA PHARMACEUTICAL : Correction to Teva, Allergan Article
07/27DJRenault Board Cuts CEO's 2016 Pay After Spat With Shareholders
07/27DJALERE : Faces Criminal Probe Over Medicare, Medicaid Billing -- Update
07/27DJALERE : Faces Criminal Probe Over Medicare, Medicaid Billing -- 2nd Update
More sector news : Pharmaceuticals - NEC
Advertisement
Income Statement Evolution
More Financials
Consensus 
Mean consensus HOLD
Number of Analysts 20
Average target price 118 $
Spread / Average Target 30%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Hendrickson President, Chief Executive Officer & Director
Mary Lauren Brlas Chairman
Judy L. Brown Chief Financial Officer & Executive Vice President
Thomas Farrington Chief Information Officer & Executive VP
Gerald K. Kunkle Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY13 002
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
More Results